首页> 外文OA文献 >Myocardial Tissue Regeneration by Cell Sheet Engineering(The 21st COE Symposium on the Frontier Regenerative Medicine)
【2h】

Myocardial Tissue Regeneration by Cell Sheet Engineering(The 21st COE Symposium on the Frontier Regenerative Medicine)

机译:细胞片工程技术再生心肌组织(第21届COE前沿再生医学座谈会)

摘要

Recently, regenerative medicine has been proposed as a new therapy for repairing damaged heart. In direct transplantation of dissociated cells, it is difficult to control shape, size and location of the transplanted grafts. To solve these problems, further advanced therapies to transplant bioengineered 3-dimensional (3-D) myocardial tissue have been investigated. In contrast to popular approach seeding cells onto 3-D biodegradable scaffolds, we have developed novel technology "cell sheet engineering" that layers cell sheets to reconstruct 3-D tissues. By using this technology, neonatal rat cardiomyocyte sheets were successfully layered and electrically communicative pulsatile 3-D myocardial tissues have been engineered. Engineered myocardial tissues grew and survived up to one year in vivo. These bioengineered myocardial tissue grafts improved damaged heart function in animal models. As next step, we have challenged to promote neovascularization in bioengineered myocardial tissues for overcoming the limitation of engineered tissue thickness. One possible idea is layering cell sheets co-cultured with endothelial cells. We confirmed the neovascular promotion when we used co-cultured cell sheets. Another technique is polysurgery of layered cell sheets at enough intervals for neovascularization. The overlaid grafts revealed synchronized beating and thicker (about 1 mm) vascularlized tissues without necrosis. These cell sheetbased technologies might contribute to tissue engineering research field as well as myocardial tissue repair.
机译:最近,已经提出了再生医学作为修复受损心脏的新疗法。在解离的细胞的直接移植中,难以控制移植的移植物的形状,大小和位置。为了解决这些问题,已经研究了进一步的先进疗法来移植生物工程的3维(3-D)心肌组织。与将细胞接种到3-D可生物降解的支架上的流行方法相反,我们已经开发了将细胞片分层以重建3-D组织的新技术“细胞片工程”。通过使用该技术,成功地对新生大鼠心肌细胞片进行了分层,并设计了电通信脉动性3-D心肌组织。工程化的心肌组织在体内生长并存活长达一年。这些经过生物工程改造的心肌组织移植物改善了动物模型中受损的心脏功能。下一步,我们挑战了生物工程化心肌组织中促进新血管形成的过程,以克服工程化组织厚度的限制。一种可能的想法是将与内皮细胞共培养的细胞片分层。当我们使用共培养的细胞片时,我们证实了新血管的促进。另一种技术是在足够的间隔内对层状细胞片进行多外科手术以进行新血管形成。覆盖的移植物显示出同步的搏动和较厚(约1 mm)的血管化组织,而没有坏死。这些基于细胞片的技术可能有助于组织工程研究领域以及心肌组织修复。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号